oligosaccharide

A compound in which monosaccharide units are joined by glycosidic linkages. The term is commonly used to refer to a defined structure as opposed to a polymer of unspecified length or a homologous mixture. When the linkages are of other types the compounds are regarded as oligosaccharide analogues.

ChEBI ID: 50699

Members (17)

Member	Definition	Role
anecortave		Poliumoside
avermectin b2a		Avermectin B2a
bullatacinone		Bullatacinone
echinacoside		echinacoside
fructooligosaccharide		fructooligosaccharide
fungitetraose		Nystose
galactomannan		6-O-Glucosylmaltose
glucose tetrasaccharide		Tetraglucoside
isomaltotetraose		Isomaltotetraose
lacto-n-triose ii		Lacto-N-triaose
landomycin a		Landomycin A
landomycin e		Landomycin E
maltooctaose		(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihy
maltotriitol		Maltotriitol
neokestose		Neokestose
scleroglucan		2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite
urdamycin b		Urdamycin B

Research

Studies (2,386)

Timeframe	Studies, Drugs in This Class (%)	All Drugs %
pre-1990	52 (2.18)	18.7374
1990's	155 (6.50)	18.2507
2000's	654 (27.41)	29.6817
2010's	1,139 (47.74)	24.3611
2020's	386 (16.18)	2.80

Study Types

Publication Type	Studies, Drugs in This Class (%)	All Drugs (%)
Trials	144 (5.71%)	5.53%
Reviews	186 (7.38%)	6.00%
Case Studies	102 (4.05%)	4.05%
Observational	12 (0.48%)	0.25%
Other	2,076 (82.38%)	84.16%